[Federal Register Volume 62, Number 120 (Monday, June 23, 1997)]
[Notices]
[Pages 33875-33876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-16322]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[INFO-97-13]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Wilma Johnson, CDC 
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 
30333. Written comments should be received within 60 days of this 
notice.

Proposed Projects

    1. Endometriosis and Exposure to Endocrine Disrupting Compounds--
New--Exposure to endocrine disrupting compounds (determined by the 
concentration of these compounds and their metabolites in serum) may be 
associated with the incidence of endometriosis. Over two years, a case-
control study will be conducted to compare serum levels of PCB's, 
pesticides, and dioxins in 50 women with newly diagnosed, 
laproscopically-confirmed endometriosis with serum levels in 50 women 
who are presumed free of endometriosis. Information on risk factors for 
endometriosis which may confound the association between endocrine 
disruptors and endometriosis will be obtained. These factors include 
demographics, smoking, and reproductive history. Information on 
potential sources of exposure to endocrine disrupting compounds (e.g.,

[[Page 33876]]

tampons and occupational or personal use of pesticides and herbicides) 
will also be obtained. The total cost to respondents is $ 0 .

----------------------------------------------------------------------------------------------------------------
                                                                      No. of       Avg. burden/                 
                   Respondents                        No. of        responses/     response (in    Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Women...........................................             100               1             .50              50
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............              50
----------------------------------------------------------------------------------------------------------------

    2. (NIOSH) Occupational Asthma Identification Methods -0920-0350--
Extension--Over the last decade, OCCUPATIONAL ASTHMA (OA) has emerged 
as the most prevalent occupational respiratory disease, resulting in 
morbidity, disability, diminished productivity, and rarely, death. 
Prevention of OA has become one of the most important goals for NIOSH. 
This project addresses these issues by examining the potential of 
different asthma screening approaches as surveillance tools when 
employed serially over time among workers at risk, and also 
characterizes the occurrence of and risk factors for occupational 
asthma in various high risk industries.
    The primary objective of the study is to examine the potential of 
different asthma screening approaches as surveillance tools when 
employed serially over time among workers at risk. A second major 
objective is to characterize the occurrence of and risk factors for 
occupational asthma in several industries, specifically workers rearing 
insects for agricultural pest control, wood product workers using 
isocyanates, and other occupational groups with different exposure 
profiles.
    A series of four groups of screening measures are applied to 
examine the potential of each measure in different situations. This 
includes a questionnaire (including an occupational history), lung 
function tests (shift spirometry, serial peak flow tests, airway 
responsiveness), inflammation and immunology tests (specific and 
nonspecific serum immunoglobulins, skin prick tests, nasal lavage for 
cellular and biochemical factors), and environmental measurements 
(gravimetric dusts, antigens, chemical vapors, viable organisms, 
endotoxins). Workers exposed to (1) high molecular weight sensitizing 
dusts, (insect particulate), (2) low molecular weight sensitizers, 
(methylene biphenyldiisocyanate, MDI), and (3) irritant but not 
sensitizing exposures, as well as a control group of unexposed workers, 
are followed for two years.
    The results should be useful in improving tools for recognition, 
monitoring, and surveillance of OA. In addition, risk factors for OA 
will be further delineated, which will assist in targeting OA 
prevention strategies for agricultural and other workers. The total 
cost to respondents is $11,960.

----------------------------------------------------------------------------------------------------------------
                                                                      No. of       Avg. burden/                 
                   Respondents                        No. of        responses/     response (in    Total burden 
                                                    respondents     respondent         hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Workers.........................................             299               2             2.0           1,196
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............           1,196
----------------------------------------------------------------------------------------------------------------

    Dated: June 13, 1997.
Wilma G. Johnson,
Acting Associate Director for Policy Planning And Evaluation, Centers 
for Disease Control and Prevention (CDC) .
[FR Doc. 97-16322 Filed 6-20-97; 8:45 am]
BILLING CODE 4163-18-P